Evaluation of itching during pregnancy

Role of bile acids in diagnosis and therapeutic effect of Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/12/010797

Enrollment

Registered

2017-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pregnant women diagnosed with intrahepatic cholestasis of pregnancy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women diagnosed with Intrahepatic Cholestasis of Pregnancy (ICP) (i.e. patients with pruritis with or without jaundice; in absence of other hepatic and dermatological causes)

Exclusion criteria

Exclusion criteria: Pruritus in pregnancy due to other causes, autoimmune liver diseases, gall bladder stone and viral hepatitis

Design outcomes

Primary

Measure	Time frame
Serum bile acid levels in ICP women versus pregnant controls with no co-morbidity and non pregnant controlsTimepoint: Baseline and at 4 weeks after treatment	—

Secondary

Measure	Time frame
Maternal and perinatal outcomeTimepoint: 4 weeks after treatment	—

Countries

India

Contacts

Public ContactNutan Agarwal

All India Institute of Medical Sciences. New Delhi, india

nutan_agarwal@yahoo.com9810107464

Outcome results